Milk Oral Immunotherapy in Children to Treat Food Allergy
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Background and Rationale
For patients with Immunoglobulin E (IgE)-mediated food allergy, the current management
includes identification of the causative food and avoidance. Specifically, among young
children, cow's milk allergy is the most common food allergy, occurring in as many as 2-3%.
Given the prevalence of milk and the difficulty to avoid it in the diet, the investigators
aim to investigate the safety and efficacy of oral immunotherapy for cow's milk allergy.
Main Objective
The primary objective is to study the efficacy of milk oral immunotherapy.
Target Population
Children aged six to 17 years with a history of cow's milk allergy will be recruited from The
Children's Hospital of Philadelphia Allergy clinical offices for the investigators study.